An Open-Label, Multicenter, Observational Study of The Effectiveness of The Cefepime/Sulbactam Antibiotic (Maxictam<sup>®</sup>-AF) In Patients With Intra Abdominal Infection, Nosocomial Pneumonia or Ventilator-Associated Pneumonia (Study MAXI-2019)

The aim of the study was to evaluate the effectiveness of cefepime/sulbactam in patients with intra-abdominal infection, nosocomial pneumonia (NP) or ventilator-associated pneumonia (VAP) in actual clinical practice. Material and methods. The study was conducted in 14 Russian Clinics from October 20...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. V. Yakovlev, M. P. Suvorova, A. O. Bykov, S. V. Zhuravel, K. A. Popugaev, L. Yu. Kulagina, I. N. Ochakovskaya, M. G. Fedorova, O. V. Pribytkova, A. A. Zateyshchikova, O. G. Malkova, T. N. Malorodova, E. S. Nekaeva, N. G. Ogonkin, Yu. A. Strezh, I. N. Sychev, O. I. Tazieva, S. G. Fominykh
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2021-02-01
Series:	Антибиотики и Химиотерапия
Subjects:	cefepime/sulbactam prospective clinical trial multicenter study nosocomial pneumonia ventilator-associated pneumonia intra-abdominal infection carbapenem-sparing therapy carbapenem-replacement therapy
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/776
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet

https://www.antibiotics-chemotherapy.ru/jour/article/view/776

An Open-Label, Multicenter, Observational Study of The Effectiveness of The Cefepime/Sulbactam Antibiotic (Maxictam<sup>®</sup>-AF) In Patients With Intra Abdominal Infection, Nosocomial Pneumonia or Ventilator-Associated Pneumonia (Study MAXI-2019)

Internet

Similar Items